API & CMOs BridgeBio API collaboration shows Yuhan's capability as a contract manufacturer for APIs; there is growth potential to expand API supply and contract manufacturing services to additional biotech and pharma partners, leveraging existing international affiliates to support global scale.

Diversified Cross-Sell Yuhan's diversified portfolio across Primary & Specialty care, dietary supplements, and household & animal care opens cross-selling opportunities to pharma distributors, retailers, and clinicians; propose bundled offerings and co-marketing with Yuhan Medica and Yuhan Chemical to reach new customer segments and channels (including e-commerce).

Global Partnerships Existing joint ventures with Janssen, Clorox, and Kimberly-Clark highlight the ability to co-develop and co-market with multinational partners; target expansion of distribution and product collaboration in Asia-Pacific and other regions to accelerate revenue growth.

Oncology & CDMO Lazertinib first-line data and ongoing oncology programs indicate demand for contract development and manufacturing services and supply for oncology assets; present Yuhan as a strategic CRO/CDMO partner for API supply, early-phase material, and scale-up manufacturing.

Digital Health Growth Recent premium supplement Mag BEX launch and consumer health tech initiatives like AI fitting room demonstrate a path to partner with retailers and consumer brands; offer white-label or co-branded products, digital wellness platforms, and data-driven marketing services to expand reach.